Literature DB >> 35033431

Letter to the Editor: Acute Coronary Syndrome Trends and COVID-19 Waves (Response to the Letter of Čulić et al.).

Nigel Sutherland1, Nalin Dayawansa2, Benjamin Filipopoulos3, Sheran Vasanthakumar2, Om Narayan2, Francis A Ponnuthurai2, William van Gaal4.   

Abstract

Entities:  

Keywords:  COVID-19 ∗ Acute coronary syndrome

Mesh:

Year:  2022        PMID: 35033431      PMCID: PMC8754509          DOI: 10.1016/j.hlc.2021.12.001

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


× No keyword cloud information.
To the Editor We would like to thank Professor Čulić and colleagues for their interest in our paper [1] and for their comments [2]. We agree that multiple factors contributed to both a reduction in acute coronary syndrome (ACS) presentations during the first and second waves of the COVID-19 pandemic in Melbourne, as well as for the rebound in presentations when restrictions were eased. In their letter. Professor Čulić et al. identify reduced air pollution and physical activity as causes for reduced ACS presentations. Public health restrictions resulted in reduced air and noise pollution levels in Melbourne during the first and second waves of the pandemic in 2020 [3]. However, when pandemic restrictions eased pollution levels returned to average which does not plausibly explain the rebound 20% increase in ACS presentations that occurred in our cohort. Similarly, restrictions reduced opportunity to participate in team sport and exercise, but possibly increased time to participate in regular physical activity. This is reflected by an Australian survey of 272 adults which reported 44% of adults reduced exertion during the pandemic, but 23% increased their physical activity [4]. The contribution of psychological stressors to ACS presentations in our cohort is difficult to ascertain. Psychological stressors were highly prevalent throughout the pandemic with a high prevalence of depression, anxiety and insomnia noted in multiple studies. Psychological distress was enhanced by isolation and unemployment [5,6]. However, our study noted a reduction in presentations when psychological stressors were high. As restrictions eased, social isolation was reduced and people returned to work, yet we found a rebound increase in ACS presentations. There are multiple possible triggers for the rebound in ACS presentations. The degree to which they contribute to the increased presentations requires further research. Increased population vulnerability during the pandemic has been well established with higher rates of snacking, smoking and alcohol consumption reported in the Australian population [7,8]. However, it is unlikely that less than one year of unhealthy lifestyles would result in a 20% increase in presentations that coincided with the easing of restrictions. In our anecdotal experience, some patients delayed presentation due to fear of contracting COVID-19 as well as a desire to avoid burdening the health care system. Identification of mechanisms that increase population cardiovascular vulnerability and trigger ACS, which can be addressed by population health measures should be a focus of further research. Campaigns have been developed to address the reduced cardiac presentations such as the American Heart Association’s ‘Don’t Die of Doubt’ campaign and the European Society of Cardiology ‘You can’t pause a heart’ effectiveness should be evaluated and adapted to improve access to cardiovascular health care [9,10]. Respectfully
  6 in total

1.  Acute Coronary Syndrome in the COVID-19 Pandemic: Reduced Cases and Increased Ischaemic Time.

Authors:  Nigel Sutherland; Nalin H Dayawansa; Benjamin Filipopoulos; Sheran Vasanthakumar; Om Narayan; Francis A Ponnuthurai; William van Gaal
Journal:  Heart Lung Circ       Date:  2021-08-25       Impact factor: 2.975

2.  Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.

Authors:  Le Shi; Zheng-An Lu; Jian-Yu Que; Xiao-Lin Huang; Lin Liu; Mao-Sheng Ran; Yi-Miao Gong; Kai Yuan; Wei Yan; Yan-Kun Sun; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  JAMA Netw Open       Date:  2020-07-01

3.  Environmental impacts of COVID-19 on Victoria, Australia, witnessed two waves of Coronavirus.

Authors:  Mahdi Boroujeni; Mohammad Saberian; Jie Li
Journal:  Environ Sci Pollut Res Int       Date:  2021-01-28       Impact factor: 5.190

4.  Smokers' cognitive and behavioural reactions during the early phase of the COVID-19 pandemic: Findings from the 2020 ITC Four Country Smoking and Vaping Survey.

Authors:  Shannon Gravely; Lorraine V Craig; K Michael Cummings; Janine Ouimet; Ruth Loewen; Nadia Martin; Janet Chung-Hall; Pete Driezen; Sara C Hitchman; Ann McNeill; Andrew Hyland; Anne C K Quah; Richard J O'Connor; Ron Borland; Mary E Thompson; Christian Boudreau; Geoffrey T Fong
Journal:  PLoS One       Date:  2021-06-04       Impact factor: 3.240

5.  The impact of COVID-19 lockdown on snacking habits, fast-food and alcohol consumption: A systematic review of the evidence.

Authors:  Dimitra Rafailia Bakaloudi; Dhanushya T Jeyakumar; Ranil Jayawardena; Michail Chourdakis
Journal:  Clin Nutr       Date:  2021-04-17       Impact factor: 7.324

  6 in total
  1 in total

Review 1.  Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses.

Authors:  Vahid Mogharab; Mahshid Ostovar; Jakub Ruszkowski; Syed Zohaib Maroof Hussain; Rajeev Shrestha; Uzair Yaqoob; Poorya Aryanpoor; Amir Mohammad Nikkhoo; Parasta Heidari; Athar Rasekh Jahromi; Esmaeil Rayatdoost; Anwar Ali; Farshid Javdani; Roohie Farzaneh; Aref Ghanaatpisheh; Seyed Reza Habibzadeh; Mahdi Foroughian; Sayyed Reza Ahmadi; Reza Akhavan; Bita Abbasi; Behzad Shahi; Arman Hakemi; Ehsan Bolvardi; Farhad Bagherian; Mahsa Motamed; Sina Taherzadeh Boroujeni; Sheida Jamalnia; Amir Mangouri; Maryam Paydar; Neda Mehrasa; Dorna Shirali; Francesco Sanmarchi; Ayesha Saeed; Narges Azari Jafari; Ali Babou; Navid Kalani; Naser Hatami
Journal:  Global Health       Date:  2022-06-08       Impact factor: 10.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.